Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2022 Filed Aug 2, 2022 16:40 UTC |
POPE CHARLES LDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-22-021021 · ownership.xml · derivative · entry 1 POPE CHARLES L · CIK 0001136354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2032-07-29 F1 · security: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · derivative.underlying_shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · balance_after: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:42 UTC |
KOSKI ROBERT CDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-22-021024 · ownership.xml · derivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2032-07-29 F1 · security: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · derivative.underlying_shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · balance_after: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:38 UTC |
Sullivan Michael O'KeefeChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-22-021018 · ownership.xml · derivative · entry 1 Sullivan Michael O'Keefe · CIK 0001542199 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-07-29 F1 · security: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022. F1 · shares: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022. F1 · derivative.exercise_date: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022. F1 · derivative.underlying_shares: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022. F1 · balance_after: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:35 UTC |
Telling FredDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-22-021015 · ownership.xml · derivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2032-07-29 F1 · security: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · derivative.underlying_shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · balance_after: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:32 UTC |
DUNTON ALAN WDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-22-021013 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2032-07-29 F1 · security: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · derivative.underlying_shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · balance_after: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:15 UTC |
Murphy Kimberly MDirector · CEO and President
|
GrantEmployee Option (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-22-017712 · ownership.xml · derivative · entry 1 Murphy Kimberly M · CIK 0001810474 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2032-06-23 F1 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company President and Chief Executive Officer. The options vest as follows: 160,000 options vest on the grant date, 160,000 options vest on December 23, 2022, 160,000 options vest on June 23, 2023, 160,000 options vest on December 23, 2023, and 160,000 options vest on June 23, 2024. The option exercise price is the Company's closing price on the date of grant. F1 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company President and Chief Executive Officer. The options vest as follows: 160,000 options vest on the grant date, 160,000 options vest on December 23, 2022, 160,000 options vest on June 23, 2023, 160,000 options vest on December 23, 2023, and 160,000 options vest on June 23, 2024. The option exercise price is the Company's closing price on the date of grant. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:15 UTC |
Sullivan Michael O'KeefeChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-22-017711 · ownership.xml · derivative · entry 1 Sullivan Michael O'Keefe · CIK 0001542199 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-06-23 F1 · security: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with interim service to the Company as Principal Executive Officer. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. F1 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with interim service to the Company as Principal Executive Officer. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. F1 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with interim service to the Company as Principal Executive Officer. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:15 UTC |
Telling FredDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-22-017710 · ownership.xml · derivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2022-06-23 F1 · security: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. F1 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. F1 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:10 UTC Amendment |
Telling FredDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-22-017831 · ownership.xml · derivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-06-23 F1 · security: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. F1 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. F2 · derivative.expiration_date: Due to a clerical error, the Form 4, as originally filed, incorrectly reported the option expiration date. The Form 4, as amended by this Form 4/A, correctly reports such information. No other changes have been made to the originally filed Form 4. F1 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 13:30 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 10,084 | $0.29 | $2,884.02 |
DisclosureSEC source: 0001493152-22-017293 · ownership.xml · nonDerivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased at an average price of $0.2860 on June 17, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 24, 2022 Filed May 25, 2022 20:05 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 78,673 | $0.29 | $22,775.83 |
DisclosureSEC source: 0001493152-22-015040 · ownership.xml · nonDerivative · entry 2 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999,916 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging between $0.2800 and $0.3000 on May 24, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:05 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 3,500 | $0.29 | $1,004.15 |
DisclosureSEC source: 0001493152-22-015040 · ownership.xml · nonDerivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 921,243 Read SEC document |
| May 20, 2022 Filed May 23, 2022 20:15 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 65,718 | $0.28 | $18,637.62 |
DisclosureSEC source: 0001493152-22-014790 · ownership.xml · nonDerivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 917,743 Read SEC document |
| May 19, 2022 Filed May 20, 2022 20:15 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 56,806 | $0.28 | $15,945.44 |
DisclosureSEC source: 0001493152-22-014605 · ownership.xml · nonDerivative · entry 2 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852,025 F1 · price: The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging between $0.2500 and $0.2700 on May 18, 2022 and between $0.2570 and $0.2998 on May 19, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:15 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 15,303 | $0.26 | $3,994.08 |
DisclosureSEC source: 0001493152-22-014605 · ownership.xml · nonDerivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 795,219 F1 · price: The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging between $0.2500 and $0.2700 on May 18, 2022 and between $0.2570 and $0.2998 on May 19, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:05 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 59,053 | $0.35 | $20,768.94 |
DisclosureSEC source: 0001493152-22-008799 · ownership.xml · nonDerivative · entry 2 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779,916 F1 · price: The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| March 30, 2022 Filed Apr 1, 2022 20:05 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 124,785 | $0.36 | $45,284.48 |
DisclosureSEC source: 0001493152-22-008799 · ownership.xml · nonDerivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720,863 F1 · price: The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 18:41 UTC |
Sullivan Michael O'KeefeInterim PEO, CFO
|
PurchaseCommon Stock | 20,000 | $0.35 | $6,922.00 |
DisclosureSEC source: 0001493152-22-008135 · ownership.xml · nonDerivative · entry 1 Sullivan Michael O'Keefe · CIK 0001542199 · Interim PEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,255 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3456 to $0.3469. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:29 UTC |
KOSKI ROBERT CDirector
|
PurchaseCommon Stock | 799,100 | $0.47 | $378,773.40 |
DisclosureSEC source: 0001493152-22-000118 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,776,483 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.44 to $0.48. F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 21:29 UTC |
KOSKI ROBERT CDirector
|
PurchaseCommon Stock | 200,900 | $0.45 | $90,364.82 |
DisclosureSEC source: 0001493152-22-000118 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 977,383 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.43 to $0.46. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 17:11 UTC |
POPE CHARLES LDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001493152-21-031895 · ownership.xml · derivative · entry 1 POPE CHARLES L · CIK 0001136354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-12-16 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 22:13 UTC |
Sullivan Michael O'KeefeInterim PEO, CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001493152-21-031897 · ownership.xml · derivative · entry 1 Sullivan Michael O'Keefe · CIK 0001542199 · Interim PEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2031-12-16 F1 · security: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021. F1 · shares: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021. F1 · derivative.exercise_date: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021. F1 · balance_after: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 22:07 UTC |
Telling FredDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001493152-21-031890 · ownership.xml · derivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-12-16 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 22:09 UTC |
KOSKI ROBERT CDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001493152-21-031893 · ownership.xml · derivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-12-16 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 22:04 UTC |
DUNTON ALAN WDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001493152-21-031888 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-12-16 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 21:10 UTC |
Murphy Kimberly MDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001493152-21-032033 · ownership.xml · derivative · entry 1 Murphy Kimberly M · CIK 0001810474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2021-12-16 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 20:06 UTC |
Telling FredDirector
|
Exercise / conversionNon-Employee Director Option (Right to Buy) · Derivative | 156,540 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001493152-21-015714 · ownership.xml · derivative · entry 2 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 156,540 shares Expires 2029-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the exercise of a fully vested outstanding option award to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan. F1 · derivative.exercise_date: Represents the exercise of a fully vested outstanding option award to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 20:06 UTC |
Telling FredDirector
|
Exercise / conversionCommon Stock | 156,540 | $0.48 | $75,139.20 |
DisclosureSEC source: 0001493152-21-015714 · ownership.xml · nonDerivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 596,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 16:35 UTC |
POPE CHARLES LDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004419 · ownership.xml · derivative · entry 1 POPE CHARLES L · CIK 0001136354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-18 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:37 UTC |
Murphy Kimberly MDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004425 · ownership.xml · derivative · entry 1 Murphy Kimberly M · CIK 0001810474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-18 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:35 UTC |
Sullivan Michael O'KeefeCFO, Secretary and Treasurer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004424 · ownership.xml · derivative · entry 1 Sullivan Michael O'Keefe · CIK 0001542199 · CFO, Secretary and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2031-02-18 F1 · security: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021. F1 · shares: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021. F1 · derivative.exercise_date: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021. F1 · balance_after: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:35 UTC |
DUNTON ALAN WDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004422 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-18 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:35 UTC |
KOSKI ROBERT CDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004423 · ownership.xml · derivative · entry 4 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-18 F1 · security: Shares owned directly by Robert C. Koski, a director of the Company. F4 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F4 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F4 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:35 UTC |
Joslyn AlanDirector · CEO and President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004421 · ownership.xml · derivative · entry 1 Joslyn Alan · CIK 0001294887 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2031-02-18 F1 · security: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021. F1 · shares: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021. F1 · derivative.exercise_date: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021. F1 · balance_after: Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:35 UTC |
Telling FredDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004420 · ownership.xml · derivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-18 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| January 14, 2021 Filed Jan 26, 2021 22:12 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 870,854 | $0.98 | $856,484.91 |
DisclosureSEC source: 0001213900-21-004433 · ownership.xml · nonDerivative · entry 8 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reporting person sold these shares of common stock on the open market. F2 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. F10 · price: This reflects the weighted average sale price. On January 14, 2021, the reporting person sold a total of 870,854 shares for a total of $859,466.01 on the open market, with the range of prices for such transactions being $0.9602 to $0.1.0068 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 13, 2021 Filed Jan 26, 2021 22:12 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 257,510 | $0.80 | $206,008.00 |
DisclosureSEC source: 0001213900-21-004433 · ownership.xml · nonDerivative · entry 7 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 870,854 F1 · kind: The reporting person sold these shares of common stock on the open market. F2 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. F9 · price: On January 13, 2021, the reporting person sold 257,510 shares on the open market at $0.8000 per share, the market price of the common stock on such date, for total proceeds of $205,994.44. Read SEC document |
| January 12, 2021 Filed Jan 26, 2021 22:12 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 629,707 | $0.73 | $460,189.88 |
DisclosureSEC source: 0001213900-21-004433 · ownership.xml · nonDerivative · entry 6 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,364 F1 · kind: The reporting person sold these shares of common stock on the open market. F2 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. F8 · price: This reflects the weighted average sale price. On January 11, 2021, the reporting person sold a total of 629,707 shares for a total of $455,441.30 on the open market, with the range of prices for such transactions being $0.7201 to $0.7501 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 11, 2021 Filed Jan 26, 2021 22:12 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 441,929 | $0.77 | $340,727.26 |
DisclosureSEC source: 0001213900-21-004433 · ownership.xml · nonDerivative · entry 5 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,758,071 F1 · kind: The reporting person sold these shares of common stock on the open market. F2 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. F7 · price: On January 11, 2021, the reporting person sold 441,929 shares on the open market at $0.7710 per share, the market price of the common stock on such date, for total proceeds of $340,710.72. Read SEC document |
| January 07, 2021 Filed Jan 26, 2021 22:12 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 323,997 | $0.84 | $272,157.48 |
DisclosureSEC source: 0001213900-21-004433 · ownership.xml · nonDerivative · entry 4 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200,000 F1 · kind: The reporting person sold these shares of common stock on the open market. F2 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. F6 · price: On January 7, 2021, the reporting person sold 323,997 shares on the open market at $0.84 per share, the market price of the common stock on such date, for total proceeds of $272,157.48. Read SEC document |
| January 06, 2021 Filed Jan 26, 2021 22:12 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 1,000,000 | $0.60 | $600,000.00 |
DisclosureSEC source: 0001213900-21-004433 · ownership.xml · nonDerivative · entry 3 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,523,997 F1 · kind: The reporting person sold these shares of common stock on the open market. F2 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. F5 · price: This reflects the weighted average sale price. On January 6, 2021, the reporting person sold a total of 1,000,000 shares for a total of $645,000 on the open market, with the range of prices for such transactions being $0.60 to $0.73 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 05, 2021 Filed Jan 26, 2021 22:12 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 500,000 | $0.58 | $290,200.00 |
DisclosureSEC source: 0001213900-21-004433 · ownership.xml · nonDerivative · entry 2 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,523,997 F1 · kind: The reporting person sold these shares of common stock on the open market. F2 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. F4 · price: On January 5, 2021, the reporting person sold 500,000 shares on the open market at $0.5804 per share, the market price of the common stock on such date, for total proceeds of $290,184.58. Read SEC document |
| January 04, 2021 Filed Jan 26, 2021 22:12 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 176,003 | $0.52 | $91,521.56 |
DisclosureSEC source: 0001213900-21-004433 · ownership.xml · nonDerivative · entry 1 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,023,997 F1 · kind: The reporting person sold these shares of common stock on the open market. F2 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. F3 · price: On January 4, 2021, the reporting person sold 176,003 shares on the open market at $0.52 per share, the market price of the common stock on such date, for total proceeds of $91,521.56. Read SEC document |
| January 02, 2021 Filed Feb 19, 2021 21:35 UTC |
KOSKI ROBERT CDirector
|
GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-004423 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,839 F1 · ownership.direct: Shares owned directly by Robert C. Koski, a director of the Company. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 23:15 UTC |
KOSKI ROBERT CDirector
|
SaleCommon Stock | 310,000 | $0.43 | $132,432.00 |
DisclosureSEC source: 0001493152-20-024267 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 776,483 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 02, 2020 Filed Dec 7, 2020 11:18 UTC |
Hernandez Joseph10% owner
|
SaleCommon Stock, $.001 par value | 5,000,000 | $0.41 | $2,051,500.00 |
DisclosureSEC source: 0001213900-20-041200 · ownership.xml · nonDerivative · entry 1 Hernandez Joseph · CIK 0001598384 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200,000 F1 · shares: On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. On December 2, 2020, the reporting person sold 5,000,000 of those shares on the open market at $0.4103 per share for total proceeds of $2,051,445.66, the market price of the common stock on such date. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 21:05 UTC |
Telling FredDirector
|
PurchaseCommon Stock | 100,000 | $0.37 | $37,000.00 |
DisclosureSEC source: 0001493152-20-022545 · ownership.xml · nonDerivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,538 F1 · price: Represents acquisition of shares of Common Stock through participation in the Company's underwritten public offering at the offering price per share of $0.37. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:30 UTC |
Joslyn AlanDirector · CEO and President
|
OtherSeries 1 Common Stock Warrants (right to buy) · Derivative | 33,333 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-20-009138 · ownership.xml · derivative · entry 1 Joslyn Alan · CIK 0001294887 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,333 shares Expires 2020-05-14 F1 · security: Represents the expiration of an unexercised outstanding Warrant in accordance with its terms. F1 · shares: Represents the expiration of an unexercised outstanding Warrant in accordance with its terms. F1 · derivative.underlying_shares: Represents the expiration of an unexercised outstanding Warrant in accordance with its terms. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:30 UTC |
Telling FredDirector
|
OtherSeries 1 Common Stock Warrants (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-20-009137 · ownership.xml · derivative · entry 1 Telling Fred · CIK 0001382225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2020-05-14 F1 · security: Represents the expiration of an unexercised outstanding Warrant in accordance with its terms. F1 · shares: Represents the expiration of an unexercised outstanding Warrant in accordance with its terms. F1 · derivative.underlying_shares: Represents the expiration of an unexercised outstanding Warrant in accordance with its terms. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:17 UTC |
Murphy Kimberly MDirector
|
GrantNon-Employee Director Option (Right to Buy) · Derivative | 138,664 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001493152-20-007670 · ownership.xml · derivative · entry 1 Murphy Kimberly M · CIK 0001810474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,664 Underlying: Common Stock · 138,664 shares Expires 2030-05-01 F1 · security: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vests immediately. F1 · derivative.underlying_shares: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vests immediately. F1 · balance_after: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vests immediately. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.